Physician profile
Helen Farrell
NPI 1235318924
$276,637.95
in general payments reported to CMS, 2019-2025
5 companies · $130K in 2025
The $130K reported for 2025 was more than what 99% of Psychiatry providers received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $284 · 2023: $54K · 2024: $93K · 2025: $130K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $231K · Travel and Lodging: $36K · Food and Beverage: $5,308 · Consulting Fee: $3,850 · Education: $35.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $231,083.00 |
| Travel and Lodging | $36,077.57 |
| Food and Beverage | $5,308.30 |
| Consulting Fee | $3,850.00 |
| Education | $35.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $276,081.40 | 2023-2025 | Spravato |
| Alkermes, INC. | $399.88 | 2022-2023 | Lybalvi |
| Neurocrine Biosciences, INC. | $82.46 | 2022 | |
| Janssen Scientific Affairs, LLC | $39.21 | 2023-2025 | Invega Sustenna, Spravato |
| Sage Therapeutics, LLC | $35.00 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Helen Farrell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.